Cannabidiol – Recent Advances

@article{Mechoulam2007CannabidiolR,
  title={Cannabidiol – Recent Advances},
  author={R. Mechoulam and Maximilian Peters and E. Murillo-Rodr{\'i}guez and L. Hanu{\vs}},
  journal={Chemistry \& Biodiversity},
  year={2007},
  volume={4}
}
The aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non‐psychoactive constituent of Cannabis, and to give a general overview. Special emphasis is laid on biochemical and pharmacological advances, and on novel mechanisms recently put forward, to shed light on some of the pharmacological effects that can possibly be rationalized through these mechanisms. The plethora of positive pharmacological effects observed with CBD make this compound a highly… Expand

Topics from this paper

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
TLDR
This review provides an overview of the chemical structure of natural and synthetic CBD derivatives including the molecular targets associated with these compounds. Expand
Potential Effects of Cannabidiol as a Wake-Promoting Agent
TLDR
This review will provide experimental evidence regarding the potential role of CBD as a wake-inducing drug and investigate the pharmacological properties of CBD with significant findings. Expand
Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice
TLDR
The effect of cannabidiol on intestinal motility in normal (control) mice and in mice with intestinal inflammation is investigated. Expand
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
TLDR
Current knowledge on the pharmacokinetics and metabolic fate of CBD in humans is summarized, studies on the biological activity of CBD metabolites either in vitro or in vivo are reviewed, and relevant drug–drug interactions are discussed. Expand
Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.
TLDR
This chapter provides an overview of the endocannabinoid system under certain physiopathological conditions, with a focus on neurological, oncologic, and metabolic disorders. Expand
the role of cannabinoids in the treatment of children with cancer
c annabinoids are a heterogeneous group of compounds that exhibit activity by binding to specific receptors called cannabinoid receptors. Cannabinoids are classified into three groups: •Expand
Cannabidiol and Multiple Sclerosis
TLDR
This chapter discusses about the different mechanisms of action of CBD, its beneficial effects on animal models of MS, and perspectives for human therapeutic treatment. Expand
Cannabinoids-Promising Antimicrobial Drugs or Intoxicants with Benefits?
TLDR
It is time to discuss whether cannabinoids are promising antimicrobial drug candidates or overhyped intoxicants with benefits. Expand
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.
  • A. Zuardi
  • Psychology, Medicine
  • Revista brasileira de psiquiatria
  • 2008
TLDR
In the last 45 years it has been possible to demonstrate that CBD has a wide range of pharmacological effects, many of which being of great therapeutic interest, but still waiting to be confirmed by clinical trials. Expand
Medicinal Use of Synthetic Cannabinoids—a Mini Review
TLDR
All the issues related to their appropriate dosage, mode of action, acute and chronic effects in vivo, interaction with other drugs, their metabolism, etc. need much research to be done so that it will be easier to predict their different aspects in human subjects in more appropriate way. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 71 REFERENCES
Cannabidiol: An Overview of Some Pharmacological Aspects
TLDR
The authors present a review on the chemistry of CBD and discuss the anticonvulsive, antianxiety, antipsychotic, antinausea, and antirheumatoid arthritic properties of CBD. Expand
Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.
TLDR
This review presents a condensed survey of the chemistry of CBD and presents evidence that it is conceivable that, in part at least, its effects are due to its recently discovered inhibition of anandamide uptake and hydrolysis and to its anti-oxidative effect. Expand
Synthesis of a primary metabolite of cannabidiol.
TLDR
This work reports the first total synthesis of 7-hydroxycannabidiol 2, a primary metabolite of cannABidiol, in an eight-step procedure, which produces numerous, potentially therapeutic pharmacological effects. Expand
The Pharmacological Actions of Cannabidiol
The major psychoactive constituent of the Cannabis sativa plant, Δ 9 -tetrahydrocannabinol (THC), has been extensively investigated for its therapeutic and toxicological effects. Cannabidiol, anotherExpand
New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.
TLDR
Surprisingly, it is found that hydrogenated CBD and CBD-DMH exhibit good binding to the cannabinoid receptor (CB(1), and demonstrate bioactivities different from their original compounds. Expand
Synthesis of cannabidiols via alkenylation of cyclohexenyl monoacetate.
TLDR
The key reaction is nickel-catalyzed allylation of 2-cyclohexene-1,4-diol monoacetate with a new reagent, (alkenyl)ZnCl/TMEDA, which gives a S(N)2-type product with 94% regioselectivity in good yield. Expand
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
TLDR
Results suggest that VR1 receptors, or increased levels of endogenous AEA, might mediate some of the pharmacological effects of CBD and its analogues, and (−)‐5′‐DMH‐CBD represents a valuable candidate for further investigation as inhibitor of AEA uptake and a possible new therapeutic agent. Expand
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.
TLDR
The hypothesis that the combination of THC and CBD increases clinical efficacy while reducing adverse events is supported, and prospects for future application of whole cannabis extracts in neuroprotection, drug dependency, and neoplastic disorders are examined. Expand
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
TLDR
Results provide preliminary evidence that cannabinoids do not exacerbate P- gp mediated MDR, and plant-derived cannabinoids are moderately effective in reversing MDR in CEM/VLB(100) cells by decreasing P-gp expression. Expand
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
TLDR
Evaluating the in vitro antiproliferative ability of cannabidiol (CBD), a nonpsychoactive cannabinoid compound, on U87 and U373 human glioma cell lines suggests a possible application of CBD as an antineoplastic agent. Expand
...
1
2
3
4
5
...